TORONTO, April 27, 2021 /CNW/ – AA Pharma, a Canadian company focused on legacy pharmaceutical products, has secured the exclusive Canadian rights for the use of a blood analyzer for patients prescribed Clozapine. This medication, indicated for patients with Treatment Resistant Schizophrenia, requires regular blood monitoring.

Read more here.

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://blog.ourcrowd.com/aa-pharma-strengthens-its-support-of-canadian-clozapine-patients-with-exclusive-rights-to-blood-analyzer/